RxDoctor Payments Data

Travis Hassell

Neurology · Nashville, TNNPI 1346599206

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (37.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 75.2% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $14,606, more than ten times the $579 reported in 2020.

$34,568in general payments, 2019–2025

Across 112 payments — averaging $308.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$26K
  • Boston Scientific$7K
  • Bayer$1K
  • Abbott$202
$272,032in research payments, 2019–2025

Across 48 payments — averaging $5667.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$261K
  • MDD US Operations, LLC$11K

What the payments were for

  • Consulting fees$12,96337%
  • Speaking & faculty fees$11,40033%
  • Travel & lodging$6,70319%
  • Food & beverage$3,50210%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)84$25,989
Boston Scientific17$7,010
Bayer10$1,367
Abbott1$202

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,568 in reported general payments places this provider in the 85th percentile of 361 neurology providers in Tennessee.

See all neurology providers in Tennessee

Medicare billing

Part B allowed, 2024
$176,954
Medicare patients
383
Services billed
8,832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine21$198,650
NuplazidPimavanserin Tartrate24$118,026
RytaryCarbidopa/Levodopa42$98,755
GocovriAmantadine Hcl18$61,481
NeuproRotigotine46$51,193
Carbidopa-LevodopaCarbidopa/Levodopa717$41,273
Droxidopa14$25,660
Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone53$13,182
Pramipexole ErPramipexole Di-Hcl16$13,005
Carbidopa-Levodopa ErCarbidopa/Levodopa138$9,176
Entacapone42$8,964
AmantadineAmantadine Hcl90$6,878
Ropinirole ErRopinirole Hcl40$6,107
Rasagiline Mesylate25$4,573
Ropinirole Hcl78$3,998

Paid to pharmacies, not to this prescriber.

Other neurology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →